Nabel's team found one of the antibodies from an HIV patient who did not become ill from the infection using a newly-invented molecular device. Further study of the patient led the researchers to discover the source of the antibody, B-cells in the immune system.

"In addition, the technique the teams used to find the new antibodies represents a novel strategy that could be applied to vaccine design for many other infectious diseases," he added.Led by a team from the NIAID Vaccine Research Center (VRC), the scientists found two naturally occurring, powerful antibodies called VRC01 and VRC02 in an HIV-infected individual's blood.They found the antibodies using a novel molecular device they developed that homes in on the specific cells that make antibodies against HIV.

15 January 2014 - UK biotech and personalised medicine company Epistem Holdings Plc (LON:EHP) said it had partnered with the US Air Force and Johns Hopkins University's Advanced Physics Laboratory to perform combat assessment of its Genedrive handheld molecular device for pathogen detection.

The business will be established as a stand-alone operating company within Danaher's $6.5B Life Sciences segment, joining the Company's Pall, Beckman Coulter Life Sciences, SCIEX, Leica Microsystems, Molecular Devices, Phenomenex and IDT businesses.

Prior to joining Halo Labs, he held various senior leadership positions including general manager at Pall ForteBio, senior VP of Instrumentation R&D at Pall, VP of Product Development at Molecular Devices, and VP of Software Engineering at Axon Instruments.

All content on this website, including dictionary, thesaurus, literature, geography, and other reference data is for informational purposes only. This information should not be considered complete, up to date, and is not intended to be used in place of a visit, consultation, or advice of a legal, medical, or any other professional.